CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Guggenheim Adjusts Price Target on Biogen to $280 From $260, Maintains Buy Rating

Positive
AI Analysis

Summary

Guggenheim increased its price target on Biogen from $260 to $280 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.30
price targetanalyst ratingequities
Related Companies

Read the original article

Published by yahoo_finance on July 21, 2026 11:05 AM

Read Original